Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in MDD with Anxiety Symptoms
NCT01814098Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Janssen Pharmaceutical. Started Jul 2009; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01814098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814098.